1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine

Cat. No.: HY-141616: FAQs
Data Sheet Handling Instructions

Molarity Calculator

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine is an endogenous metabolite present in Blood that can be used for the research of Pregnancy and Sepsis.

For research use only. We do not sell to patients.

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine Chemical Structure

CAS No. : 50930-23-9

Size	Price	Stock	Quantity
10 mg	USD 170	Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
50 mg		Get quote
100 mg		Get quote

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of 1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine:

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine-d₅ Get quote

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine is an endogenous metabolite present in Blood that can be used for the research of Pregnancy and Sepsis^[1]^[2]^[3].
In Vitro	Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine Related Antibodies
Molecular Weight	509.66
Formula	C₂₅H₅₂NO₇P
CAS No.	50930-23-9
SMILES	CCCCCCCCCCCCCCCCC(OC[C@@H](O)COP(OCC[N+](C)(C)C)([O-])=O)=O
Structure Classification	Others
Initial Source	Endogenous metabolite
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (261 KB) Handling Instructions (2659 KB)
References	[1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief] [2]. Bahado-Singh RO, et al. Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. [Content Brief] [3]. Ferrario M, et al. Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach. Sci Rep. 2016 Feb 5;6:20391. [Content Brief]